Alexandra Della Pia

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Venues

Cancers

Leukemia & lymphoma

Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Neil J Shah, Alexandra Della Pia, Tianmin Wu, Aquino Williams, Melinda Weber, Brittany Sinclaire, Elli Gourna Paleoudis, Adil Alaoui, Shaked Lev-Ari, Shari Adams, Jordan Kaufman, Sahil B Parikh, Emily Tonti, Eric Muller, Michael Serzan, Divya Cheruku, Albert Lee, Aishwarya Sridhar, Benjamin Thor Perrin Hee, Jaeil Ahn, Andrew Pecora, Andrew Ip, Michael B Atkins
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Cancers 16 (12) (2024)
Scott Douglas Rowley, Thomas S Gunning, Michael Pelliccia, Alexandra Della Pia, Albert Lee, James Behrmann, Ayrton I Bangolo, Parul Jandir, Hong Zhang, Sukhdeep Kaur, Hyung C Suh, Michele Donato, Maher Albitar, Andrew Ip
Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation. Cancers 16 (7) (2024)
Neil J Shah, Alexandra Della Pia, Tianmin Wu, Aquino Williams, Melinda Weber, Brittany Sinclaire, Elli Gourna Paleoudis, Adil Alaoui, Shaked Lev-Ari, Shari Adams, Jordan Kaufman, Sahil B Parikh, Emily Tonti, Eric Muller, Michael Serzan, Divya Cheruku, Albert Lee, Aishwarya Sridhar, Benjamin Thor Perrin Hee, Jaeil Ahn, Andrew Pecora, Andrew Ip, Michael B Atkins
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Cancers 16 (12) (2024)
Neil J Shah, Alexandra Della Pia, Tianmin Wu, Aquino Williams, Melinda Weber, Brittany Sinclaire, Elli Gourna Paleoudis, Adil Alaoui, Shaked Lev-Ari, Shari Adams, Jordan Kaufman, Sahil B Parikh, Emily Tonti, Eric Muller, Michael Serzan, Divya Cheruku, Albert Lee, Aishwarya Sridhar, Benjamin Thor Perrin Hee, Jaeil Ahn, Andrew Pecora, Andrew Ip, Michael B Atkins
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Cancers 16 (12) (2024)
Scott Douglas Rowley, Thomas S Gunning, Michael Pelliccia, Alexandra Della Pia, Albert Lee, James Behrmann, Ayrton I Bangolo, Parul Jandir, Hong Zhang, Sukhdeep Kaur, Hyung C Suh, Michele Donato, Maher Albitar, Andrew Ip
Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation. Cancers 16 (7) (2024)
Andrew Ip, Alessandra Petrillo, Alexandra Della Pia, Gee Youn Geeny Kim, Sarvarinder Gill, Tony Varughese, Joshua Zenreich, Martin Gutierrez, Jiayu Zhang, Jaeil Ahn, Vishnu Bharani, Ava S Nejad, Lauren Pascual, Tatyana A Feldman, Lori A Leslie, Andre H Goy
Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma. Leukemia & lymphoma (2023)
Shaked Lev-Ari, Michael Serzan, Tianmin Wu, Andrew Ip, Lauren Pascual, Brittany Sinclaire, Shari Adams, Michael Marafelias, Lakshmi Ayyagari, Sarvarinder K Gill, Barbara Ma, Jacob P Zaemes, Alexandra Della Pia, Adil Alaoui, Subha Madhavan, Anas Belouali, Andrew Pecora, Jaeil Ahn, Michael B Atkins, Neil J Shah
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study. Cancer (2023)

Alexandra Della Pia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alexandra Della Pia